跳至主要内容
临床试验/NCT01243736
NCT01243736已完成1 期

Assessment of Combined Bowel Preparation for Capsule Endoscopy Study

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2010年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Mayo Clinic
入组人数
50
试验地点
1
主要终点
Improvement small bowel visualization, diagnostic yield, and complete rate of capsule endoscopy

研究概览

简要总结

The investigators are conducting a study to see if taking a bowel preparation before having a capsule endoscopy is more helpful than the standard preparation of not eating after 7 PM the night before a capsule endoscopy in making it easier to see the small bowel in order to find the source of gastrointestinal bleeding.

详细描述

This is a single-blind, prospective randomized controlled study to determine if a combination of purgative agent, prokinetic agent, simethicone, and position will improve small bowel visualization, diagnostic yield, and completion rate of capsule endoscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years old
  • Gastrointestinal bleeding as indication for capsule endoscopy.
  • Ability to give informed consent

排除标准

  • Subject has an allergy to polyethylene glycol or other adverse reaction to a previous bowel preparation with PEG3350 (MoviPrep®), metoclopramide, or simethicone;
  • Subjects has gastrointestinal motility disorder;
  • Subjects had stomach or small bowel resection;
  • Subjects has pheochromocytoma;
  • Subjects has uncontrolled hypertension;
  • Subjects has seizure disorders;
  • Subjects has concurrent MAO inhibitor use;
  • Subject has G6PD deficiency;
  • Subjects has swallowing disorder (including impaired gag reflex);
  • Subjects has hyponatremia with serum sodium less than 130 mm0l/L

研究组 & 干预措施

Combination Prep

Active Comparator

The other group will receive the combination bowel preparation, which consists of taking the standard bowel preparation plus:

  1. drinking 2-liters (8 cups) of polyethylene glycol starting at 7 p.m. the night prior to the capsule endoscopy test;
  2. drinking a teaspoon of simethicone 20 minutes prior to the capsule endoscopy test;
  3. drinking a teaspoon of metoclopramide 20 minutes prior to the capsule endoscopy test;
  4. lying on your right side for 30 minutes following the swallowing of the capsule endoscope.

干预措施: Combination Prep (Drug)

结局指标

主要结局

Improvement small bowel visualization, diagnostic yield, and complete rate of capsule endoscopy

时间窗: 1 year

The primary endpoints of small bowel visualization quality, diagnostic yield, and completion rate will be compared between groups using Pearson's chi-square test.

次要结局

  • gastric transit time(1 year)
  • Safety outcomes and Patient satisfaction(1 year)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Stephanie L. Hansel

Assistant Professor of Medicine

Mayo Clinic

研究点 (1)

Loading locations...

相似试验